|
| 產(chǎn)地 | 進(jìn)口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS12358 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-SEN1/Mortality factor 4-like protein 1 |
| 克隆性 | 是 |
| 靶點(diǎn) | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human Mortality factor 4-like protein 1 |
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：
1. 細(xì)胞衰老相關(guān)蛋白1抗體規(guī)格 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來篩選最適條件；
3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合；
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
產(chǎn)品訂購信息：
英文名稱 Anti-SEN1/Mortality factor 4-like protein 1
中文名稱 細(xì)胞衰老相關(guān)蛋白1抗體規(guī)格
別 名 Cell senescence related gene complementation group B; Cellular senescence related protein 1; CSR; CSRB; MORF 4; MORF4; MORF4 protein; Mortality factor 4; SEN 1; SEN; Senescence (cellular) related 1; Senescence related cellular 1; Transcription factor like protein MORF4; MO4L1_HUMAN; Mortality factor 4-like protein 1; MORF-related gene 15 protein; Protein MSL3-1; Transcription factor-like protein MRG15.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Cow, Zebrafish
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 細(xì)胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子 表觀遺傳學(xué)
蛋白分子量 predicted molecular weight: 27kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Mortality factor 4-like protein 1
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
細(xì)胞衰老相關(guān)蛋白1抗體規(guī)格 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Cellular senescence, the terminal nondividing state that normal cells enter following completion of their proliferative potential, is the dominant phenotype in hybrids of normal and immortal cells. Fusions of immortal human cell lines with each other have led to their assignment to one of several complementation groups. SEN1 or MORF4 is a gene on chromosome 4 that induces a senescent-like phenotype in cell lines assigned to complementation group B. It is capable of reversing the immortal phenotype of a subset of immortal cells. Overexpression of SEN1 in HeLa cells ultimately caused abnormal nuclear morphology and cell death.
Function : Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. NuA4 may also play a direct role in DNA repair when directly recruited to sites of DNA damage. Also component of the mSin3A complex which acts to repress transcription by deacetylation of nucleosomal histones. Required for homologous recombination repair (HRR) and resistance to mitomycin C (MMC). Involved in the localization of PALB2, BRCA2 and RAD51, but not BRCA1, to DNA-damage foci.
Subunit : Component of the NuA4 histone acetyltransferase complex which contains the catalytic subunit KAT5/TIP60 and the subunits EP400, TRRAP/PAF400, BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2, ING3, actin, ACTL6A/BAF53A, MORF4L1/MRG15, MORF4L2/MRGX, MRGBP, YEATS4/GAS41, VPS72/YL1 and MEAF6. The NuA4 complex interacts with MYC and the adenovirus E1A protein. MORF4L1 may also participate in the formation of NuA4 related complexes which lack the KAT5/TIP60 catalytic subunit, but which include the SWI/SNF related protein SRCAP. Component of the mSin3A histone deacetylase complex, which includes SIN3A, HDAC2, ARID4B, MORF4L1, RBBP4/RbAp48, and RBBP7/RbAp46. Interacts with RB1 and KAT8. May also interact with PHF12 and one or more as yet undefined members of the TLE (transducin-like enhancer of split) family of transcriptional repressors. Interacts with the N-terminus of MRFAP1. Found in a complex composed of MORF4L1, MRFAP1 and RB1. Interacts with the entire BRCA complex, which contains BRCA1, PALB2, BRCA2 and RAD51. Interacts with PALB2.
Subcellular Location : Nucleus.
Similarity : Contains 1 MRG domain.
Database links : UniProtKB/Swiss-Prot: Q9UBU8.2
NCBI Reference Sequence: NP_006783.2
抗體的鑒定：
1）細(xì)胞衰老相關(guān)蛋白1抗體規(guī)格 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來鑒定。
2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力?？贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。
甘露醇發(fā)酵培養(yǎng)基250g生化試驗(yàn)培養(yǎng)基，用于細(xì)菌(如金黃色葡萄球菌)甘露醇發(fā)酵試驗(yàn)(GB標(biāo)準(zhǔn))
煌綠乳糖膽鹽肉湯(BGLB) 1000(g) incubation media 煌綠乳糖膽鹽肉湯(BGLB) 1000(g)
LB肉湯 LB Broth 250克 用于分子生物學(xué)實(shí)驗(yàn)中大腸桿菌的保存和培養(yǎng)
40%尿素水5ml*尿素酶瓊脂基礎(chǔ)incubationmedia40%尿素水5ml*尿素酶瓊脂基礎(chǔ)
RVSBroth
甘露醇化瓊脂培養(yǎng)基24020250g用于金黃色葡萄球菌的選擇性分離培養(yǎng)和計(jì)數(shù)(《中華人民共和國藥典》20。
LB Broth Agar 培養(yǎng)基 250g incubation media LB Broth Agar 培養(yǎng)基 250g
亞黃八疊球菌 支/瓶
theSmallestBrothMedium
堿性L-G培養(yǎng)基基礎(chǔ) 250g 用于酸性物質(zhì)處理的結(jié)核桿菌標(biāo)本
精酸葡萄糖斜面瓊脂(AGS)于霍亂弧菌的復(fù)合生化試驗(yàn)(SN標(biāo)準(zhǔn))
ModifiedFreyMedium
DG-18瓊脂 DICHLORANGLYCEROL (DG-18) AGAR 250 用于食品中霉菌和酵母菌分離培養(yǎng)(Acumedia方法)
乳糖莫能霉素葡萄糖醛酸瓊脂LMG250g/瓶用于大腸菌群濾膜法檢測(cè)incubationmedia乳糖莫能霉素葡萄糖醛酸瓊脂LMG250g/瓶用于大腸菌群濾膜法檢測(cè)
哥倫比亞血瓊脂平板(9cm) 10個(gè)/包 用于營養(yǎng)要求高細(xì)菌的分離、培養(yǎng)和溶血試驗(yàn)
CL-0191RBE(人細(xì)胞)5×106cells/瓶×2
CA1 Others Human 人 CA1 人細(xì)胞裂解液 (陽性對(duì)照)
小鼠腸平滑肌細(xì)胞完全培養(yǎng)基 100mL
MS1小鼠胰島內(nèi)皮細(xì)胞 MS1 mouse islet endothelial cells DMEM培養(yǎng)基+5%FBS
CLCF1 Protein Human 重組人 N1 / CLCF1 / CLC 蛋白 (Fc 標(biāo)簽)
RAG(小鼠腎腺癌細(xì)胞) 5×106cells/瓶×2 H08910(細(xì)胞)
細(xì)胞衰老相關(guān)蛋白1抗體規(guī)格CL-0188QGY-7701(人細(xì)胞)5×106cells/瓶×2
TSPAN1 Others Human 人 TSPAN1 (aa 110-211) 人細(xì)胞裂解液 (陽性對(duì)照)
人臍平滑肌細(xì)胞裂解物HUVSMCL
MB-271細(xì)胞，人癌細(xì)胞 中國倉鼠腎細(xì)胞(二氫葉酸還原酶缺陷型),CHO/dhFr-細(xì)胞 角膜上皮細(xì)胞Many types of cells包裝：5 × 105次方(1ml)
AML-193(人急性單核細(xì)胞單核細(xì)胞) 5×106cells/瓶×2
NHEM.f Pellet 正常人表皮黑素細(xì)胞團(tuán)塊(少年者) > 1 mio.cells 人腸平滑肌細(xì)胞裂解物HISMCL
|
|
|
|
|
